ACCEPT SIMS AI™ · BloomShield CIC

BloomShield-branded research demonstrator

RESEARCH DEMONSTRATOR — SYNTHETIC DATA ONLY — NOT FOR CLINICAL USE

Synthetic-data research demonstration · Mock mode — simulated responses, no live AI · Not for clinical use.

Integrated demonstration

Synthetic data only · Not for clinical use. Administrative decisions never establish diagnostic completion.

Load EXP-0885 · Site E · 15 November 2026

Load the fixed scenario above to follow the demonstration. Other filters and dates retain their own historical context.

Which intelligence is being demonstrated?
  • Model A: trained referral-time prediction evaluated on synthetic data, with a 60-day horizon and historical-cutoff safeguards.
  • Event-triggered review: deterministic navigation intelligence based on documented events; no new probability.
  • Generative AI: model-generated administrative recommendations in safeguarded Live mode. Mock mode uses a deterministic fixture and makes no model call.
  • Model B: proposed future dynamic prediction, not yet trained or implemented; no probability is available.
Uploads

Planned ingestion capabilities — not yet operational. This demonstration uses a fixed synthetic cohort.

  • Direct entry with mobile-friendly forms and future offline capabilities.
  • Validated CSV/Excel imports with schema, chronology and data-quality checks.
  • Secure integrations with existing records, laboratory and appointment systems, potentially using HL7 FHIR.

Programme dashboard

Screening activity and follow-up across the synthetic programme.

Site
Screening modality

Programme activity

Unique participants screened
777
Screening encounters
781
Diagnostic referrals
140
Outstanding pathways
90

Screening pathway

  1. Screening781Encounters
  2. Positive finding254Documented findings
  3. Referral140Diagnostic referrals
  4. Follow-up115Diagnostic visits
  5. Outcome50Resolved pathways

Stage totals use different units. Pending pathways: 90. Insufficient observation: 0.

Participant insight

Expanded synthetic participant 0652 · EXP-0652Synthetic · Site A

Full participant history through 2025-05-21, across modalities and pathways.

  1. · Screening · VIA · Initial · Programme entry
  2. · Screening result · VIA · VIA positive · Adequate
  3. · Repeat plan · HPV DNA · Prior VIA positive · Scheduled for 2025-08-17
  4. · Diagnostic referral · EXP-0652-T-R
  5. · Contact attempt · Reached
  6. · Diagnostic booking · Initial booking
  7. · Barrier documented · Appointment coordination
  8. · Barrier documented · Contact difficulty
  9. · Diagnostic visit · Missed
  10. · Diagnostic booking · Rebooking
  11. · Navigation intervention · Coordination support
  12. · Diagnostic visit · Attended
  13. · Diagnosis · Colposcopy · Biopsy collected
  14. · Diagnosis · Histopathology · No high-grade lesion identified
  15. · Surveillance plan · HPV DNA · After clinical assessment · Scheduled for 2026-05-05
  16. · Follow-up disposition · Resolved · EXP-0652-T-R

Referral-time risk

Pathway status at observation · Resolved

Loading prediction…

Observed day-60 outcome · Unresolved

Screened participants

777 matching participants. Select a participant to review their timeline and referral-time risk.

ParticipantSite
EXP-0648 · Expanded synthetic participant 0648Site C — Rural Outreach Programme
EXP-0652 · Expanded synthetic participant 0652Site A — Urban Referral Hub
EXP-0657 · Expanded synthetic participant 0657Site D — Community Engagement Programme
EXP-0658 · Expanded synthetic participant 0658Site C — Rural Outreach Programme
EXP-0661 · Expanded synthetic participant 0661Site C — Rural Outreach Programme
EXP-0666 · Expanded synthetic participant 0666Site C — Rural Outreach Programme
EXP-0672 · Expanded synthetic participant 0672Site D — Community Engagement Programme
EXP-0674 · Expanded synthetic participant 0674Site E — Resource-Constrained Navigation Programme
EXP-0689 · Expanded synthetic participant 0689Site D — Community Engagement Programme
EXP-0700 · Expanded synthetic participant 0700Site B — Peri-Urban Access Programme
EXP-0702 · Expanded synthetic participant 0702Site D — Community Engagement Programme
EXP-0704 · Expanded synthetic participant 0704Site A — Urban Referral Hub
EXP-0714 · Expanded synthetic participant 0714Site B — Peri-Urban Access Programme
EXP-0722 · Expanded synthetic participant 0722Site E — Resource-Constrained Navigation Programme
EXP-0726 · Expanded synthetic participant 0726Site B — Peri-Urban Access Programme
EXP-0727 · Expanded synthetic participant 0727Site C — Rural Outreach Programme
EXP-0730 · Expanded synthetic participant 0730Site C — Rural Outreach Programme
EXP-0747 · Expanded synthetic participant 0747Site B — Peri-Urban Access Programme
EXP-0750 · Expanded synthetic participant 0750Site E — Resource-Constrained Navigation Programme
EXP-0757 · Expanded synthetic participant 0757Site D — Community Engagement Programme
EXP-0762 · Expanded synthetic participant 0762Site C — Rural Outreach Programme
EXP-0776 · Expanded synthetic participant 0776Site B — Peri-Urban Access Programme
EXP-0780 · Expanded synthetic participant 0780Site D — Community Engagement Programme
EXP-0782 · Expanded synthetic participant 0782Site D — Community Engagement Programme
EXP-0789 · Expanded synthetic participant 0789Site E — Resource-Constrained Navigation Programme

Programme insights

Encounters by modality

VIA
356
HPV DNA
312
Cytology
113

Navigation activity

Barrier documented
95
Contact attempt
195
Navigation intervention
39
Diagnostic booking
159
Diagnostic visit
115

Documented barriers

Contact difficulty
27
Transport difficulty
33
Appointment coordination
35

Site and modality select screening encounters. Pathway status limits the screened group to participants with a matching referral. Referral, navigation and barrier totals count events linked to matching pathways.